Connect with us

IT

Security Matters (ASX:SMX) – Haggai Alon

Published

on

The CEO Mindset - Haggai Alon is the Founder and CEO of Security Matters (ASX:SMX)

Haggai Alon is the Founder and CEO of Security Matters (ASX:SMX), a company that owns and has commenced commercializing the technology to permanently and irrevocably “mark” any object either solid, liquid or gas, allowing identification, proof of authenticity, tracking supply chain movements & quality assurance. Security Matters’ vision is to become the global record for physical goods through its unique technology for asset tracking and its ability to create a “Physical to Digital Twin”.

What’s your journey in becoming a CEO?
After I left school I joined the Israeli military and remained there for five years. Once I left the army I started working in education and community work and then mergers and acquisition in traditional industry. From there I began working with the Israeli Government helping them commercialise technology. I was always on the lookout for tech that stood out. The pure chemistry and physics behind Security Matters was exactly the type of tech I was looking for – stable, scalable and able to be implemented across a wide range of industries. I founded Security Matters and became CEO.

Tell us a bit about your business and how you are commercializing?
We are a white label B2B company and our strategy is to integrate ourselves into big brands to not only become part of their supply chain but an enabler to the circular economy and therefore an integral part of their sustainability strategy. This strategy is working well for us and we currently have research projects with some of the biggest companies in fashion, plastics and resources.

How are you managing with the current COVID-19 pandemic on both business and personal front?
Security Matters is considered to be an essential business in Israel so, for me, it has been business as usual professionally. Personally, I have, for the first time in many years, spent two full months in the country. It has been amazing to have this time with my family.

What’s the most exciting thing about running your business?
The scope of the technology is very exciting and that has attracted some really wonderful and creative people to our team. I find working with them the most exciting aspect about my business.

How do you measure success?
Initially, I thought I would consider myself successful once I was able to publicly float Security Matters. We listed on the Australian Stock Exchange in 2018 and it was a hugely satisfying moment but it made me realise that there was a lot yet to achieve, both professionally and personally, before I considered myself truly successful.

What do you think is the most important quality of being a CEO of a listed company?
Being able to build, manage and grow a team. This is the backbone of any successful business. 

What is your favourite book?
The Little Prince by Antoine de Saint-Exupéry – I read it as a child and I read it to my children. The themes of isolation, fear, uncertainty and love are timeless and every time I read it I find new meaning as well as a deep, familial comfort.

What message do you want to send to our readership in Asia?
One thing that COVID-19 has done is to show the world exactly how connected and reliant on each other we are. It has created fear but also love and generosity which I hope we can remember and retain after this time is over.

How can people connect with you?
Email: info@securitymattersltd.com
Website: http://www.securitymattersltd.com/

Want to be on the list next time this company raises capital? Open an account with Fresh Equities and start exploring capital raises – freshequities.com

Security Matters (ASX:SMX) Board Members And Key Management

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

IT

Q&A With StockPal – JCurve Solutions (ASX:JCS)

Published

on

Q&A with StockPal - Stephen Canning, Chief Executive Officer of JCurve Solutions (ASX:JCS)

Watch Stephen Canning, Chief Executive Officer of JCurve Solutions (ASX:JCS) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following questions:

0:11 – What is your business about?
0:49 – How did your company cope with the COVID-19 pandemic?
5:47 – How does the company make money?
7:39 – Who are your target customers and key markets?
9:22 – What is JCurves’ competitive advantage?
11:53 – How are you currently engaging with your investors and what are those plans?

Visit JCS’s website to learn more about their story: https://www.jcurvesolutions.com/

Email editor@stockpal.asia if you are or represent a listed-company and is keen to be in our interviews.

Want to be on the list next time this company raises capital? Open an account with Fresh Equities and start exploring capital raises – freshequities.com

Continue Reading

IT

Q&A With StockPal – Frugl (ASX:FGL)

Published

on

Q&A with StockPal - Sean Smith, Chief Executive Officer of Frugl (ASX:FGL)

Watch Sean Smith, Chief Executive Officer of Frugl (ASX:FGL) and Jared Sim, Editor-in-Chief and Co-Founder of StockPal in this engaging Q&A with the following questions:

0:09 – What is your business about?
1:15 – How did your company cope with the COVID-19 pandemic?
2:27 – How does the company make money?
3:11 – Who are your target customers?
3:49 – What is your firm’s competitive advantage?
4:55 – How are you currently engaging with your investors?

Visit Frugl’s website to learn more about their story: https://fruglgroup.com/

Email editor@stockpal.asia if you are or represent a listed-company and is keen to be in our interviews.

Want to be on the list next time this company raises capital? Open an account with Fresh Equities and start exploring capital raises – freshequities.com

Continue Reading

IT

On the back of a NASDAQ listing, could MYQ play a bigger role in digital health?

Published

on

On the back of a NASDAQ listing, could MYQ play a bigger role in digital health?

The inability to determine why some people contract the disease, while others present little or no symptoms at all has been one of the greatest mysteries of the COVID-19 pandemic.

It seems there is no clear answer to this question.

What we do know is the elderly are the most susceptible, however people as young as 30 have, in rare instances, succumbed to the virus. And according to France’s chief epidemiologist young people with obesity are also at risk.

Until there is a vaccine, we have to live with the uncertainty.

However, there are ways to mitigate the risk and if 2020 has taught us anything, health tech is at the forefront of mitigation practices.

Digital health services have been growing since 2018. Digital health companies raised US$8.1 billion in venture capital financing in 2018.

The primary driver of this and subsequent growth in this sector is the need to improve patient experience and engagement.

The basic concepts underpinning this improvement are new medical devices that have already been embraced and proven effective across the healthcare industry, demonstrating clinical and financial value.

Monitoring and communicating critical data from home is convenient and time effective without needing face-to-face consultation.

Wearables, for instance, have moved ahead in leaps and bounds as at home devices save patients a trip to the doctor or hospital and in some cases, even saved lives.

Livongo is one company in recent times that has really embraced digital health, to the point that Teledoc is merging with Livongo Health in an $18.5BN deal that will create a leader in consumer-centred virtual health care.

Meanwhile Google and Fitbit combined to monetise health data, when Google purchased the original wearable giant for $2BN.

Amazon has also moved into 3D body scans and announced Halo, a fitness band and app that scans your body and voice.

Even IBM and Samsung are getting in on the health tech trend.

At a local level, MyFiziq Limited (ASX: MYQ) has been fighting the good fight.

MYQ has developed a patented application that allows an individual to accurately track the dimensions of their body directly from a smartphone.

The application measures body fat indirectly through machine learning and body shape analysis.

It also utilises surrogate measures of a person’s total body fat mass, such as BMI, waist circumference, waist to hip ratio and waist to height ratio. These surrogate methods have been significantly associated with non-communicable diseases directly correlated with obesity.

The company is focused on delivering its app to several key verticals worth collectively trillions of dollars including health and fitness, medical and insurance, corporate wellness, apparel, telehealth and mobile health.

In fact, several health organisations and insurance companies have already adopted MYQ’s tech as a means to help their clients and customers achieve optimum health targets.

A number of recent deals should push the company into profitability in the coming months.

MYQ requires 140,000 users paying US$1.50 per month to break even. A quick scan of their most recent deals shows this to be well within reach:

  • Nexus-Vita – Initial Target users of 100,000, minimum annual revenue to MYQ of US$3.58M from date of commercial launch (due Jan 2021);
  • Jayex Healthcare (ASX: JHL) – Initial target of 1,000,000 users – starts Q1 of 2021;
  • Biomorphik – Initial user target of 100,000 – release date Q4 2020.

Numerous other deals are expected to grow MYQ’s user base throughout 2021, complementing its existing partnerships with Evolt and Bearn (400,000 initial user target) – which has MYQ technology available on both the Apple App Store and Google Play Store.

As it looks to capitalise on its current momentum, along with the adoption of digital health, MYQ has turned its focus to its proposed NASDAQ listing.

MYQ has engaged US based investment bank Ladenburg Thalmann & Co. Inc. as lead underwriter to its proposed NASDAQ IPO.

In the much bigger US market, that is more familiar with the potential upside of health tech companies, MYQ’s ASX shareholders could be rewarded once the US listing is completed.

COVID continues to highlight the benefits of technology, including health-tech in what has now been dubbed “the new normal”.

Companies are scrambling to get their health tech right to, as stated, improve patient experience and engagement.

Meanwhile, investors, including Robinhood investors who are new to investing, are looking for ethical and worthy companies to put their money into. Notably, Robinhood investors have been driving the growth of NASDAQ listed health and tech stocks.

MYQ’s NASDAQ listing and wider exposure to US investors, could be a further shot in the arm for the company and its shareholders, as it rolls out its tech to broader markets.

Continue Reading

Get more stuff

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Recent Posts

Categories

Trending